Batu Biologics Recruits Dr. Vijay Mahant to SAB

Batu Biologics Recruits Diagnostics Expert to Oversee Precision-Medicine Company Arm

Vijay Mahant, PhD, will lead efforts in the development of gene-guided precision medicine related to the ValloVax immune therapy

Batu Biologics, an immuno-oncology company dedicated to the development of its tumor-angiogenesis targeting immune therapy, ValloVax™, announced today the appointment of Vijay Mahant, PhD, to its Scientific Advisory Board.

Read the full article at businesswire.com

0